These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28446169)

  • 21. Performance of the Xpert
    Hoyos-Mallecot Y; Ouzani S; Dortet L; Fortineau N; Naas T
    Int J Antimicrob Agents; 2017 Jun; 49(6):774-777. PubMed ID: 28411078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan.
    Blakiston M; Heffernan H; Roberts S; Freeman J
    N Z Med J; 2017 Apr; 130(1454):72-79. PubMed ID: 28449019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
    Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
    J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine active surveillance for carbapenemase-producing Enterobacteriaceae from rectal swabs: diagnostic implications of multiplex polymerase chain reaction.
    Lowman W; Marais M; Ahmed K; Marcus L
    J Hosp Infect; 2014 Oct; 88(2):66-71. PubMed ID: 25082751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation demand from carbapenemase-producing Enterobacteriaceae screening strategies based on a West London hospital network.
    Vella V; Moore LS; Robotham JV; Davies F; Birgand GJ; Otter JA; Brannigan E; Dyakova E; Knight GM; Mookerjee S; Holmes AH
    J Hosp Infect; 2016 Oct; 94(2):118-24. PubMed ID: 27209055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection due to travel-related carbapenemase-producing Enterobacteriaceae, a largely underestimated phenomenon in Belgium.
    Jans B; D Huang TD; Bauraing C; Berhin C; Bogaerts P; Deplano A; Denis O; Catry B; Glupczynski Y
    Acta Clin Belg; 2015 Jun; 70(3):181-7. PubMed ID: 25825036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemic increase in the incidence of carbapenemase-producing Enterobacteriaceae in Denmark].
    Wang M; Ellermann-Eriksen S; Hansen DS; Kjerulf A; Fuglsang-Damgaard D; Holm A; Østergaard C; Røder B; Sönksen UW; Detlefsen M; Hansen F; Hasman H; Hammerum A; Skov RL
    Ugeskr Laeger; 2016 Nov; 178(45):. PubMed ID: 27855770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
    Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
    Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.
    Legeay C; Hue R; Berton C; Cormier H; Chenouard R; Corvec S; Birgand G
    J Hosp Infect; 2019 Feb; 101(2):183-187. PubMed ID: 30389597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of carbapenemase-producing genes in referral Enterobacteriaceae in South Africa: A short report.
    Perovic O; Britz E; Chetty V; Singh-Moodley A
    S Afr Med J; 2016 Sep; 106(10):975-977. PubMed ID: 27725012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á; Cantero M; Shaw E; Vergara-López S
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of carbapenemase-producing Enterobacteriaceae in the West Midlands region of England: 2007-14.
    Findlay J; Hopkins KL; Alvarez-Buylla A; Meunier D; Mustafa N; Hill R; Pike R; McCrae LX; Hawkey PM; Woodford N
    J Antimicrob Chemother; 2017 Apr; 72(4):1054-1062. PubMed ID: 28073969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients.
    Lapointe-Shaw L; Voruganti T; Kohler P; Thein HH; Sander B; McGeer A
    Eur J Clin Microbiol Infect Dis; 2017 Jun; 36(6):1047-1055. PubMed ID: 28078557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment.
    Cheng VC; Chen JH; So SY; Wong SC; Chau PH; Wong LM; Ching RH; Ng MM; Lee WM; Hung IF; Ho PL; Yuen KY
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1418-1425. PubMed ID: 27619653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
    Fattouh R; Tijet N; McGeer A; Poutanen SM; Melano RG; Patel SN
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1556-9. PubMed ID: 26711746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].
    Leenstra T; Bosch T; Vlek AL; Bonten MJM; van der Lubben IM; de Greeff SC
    Ned Tijdschr Geneeskd; 2017; 161():D1585. PubMed ID: 29076442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbapenemase-producing Enterobacteriaceae in Australian hospitals: outcome of point-prevalence screening in high-risk wards.
    Brett JA; Johnson SA; Cameron DRM; Lane CR; Easton M; van Diemen A; Sutton B; Bull AL; Richards MJ; Worth LJ
    J Hosp Infect; 2019 Feb; 101(2):163-166. PubMed ID: 30102948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.